US Regulation Could Delay Introduction of PBRER as ICH Standard

There is a growing possibility that a US regulation will delay the introduction of the Periodic Benefit Risk Evaluation Report (PBRER) as the new standard for the ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for...read more